ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,428.13
0.16%
Dow Jones
39,558.11
0.32%
Gold vs US Dollar
2,356.565
0.75%
Brent Oil
82.55
-0.79%
Bitcoin
61,710.01
-1.90%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Trinity Biotech PLC (TRIB)

  7. Trinity Biotech PLC (TRIB) News

Trinity Biotech (TRIB)

Trinity Biotech PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TRIB
DateTimeSourceHeadlineSymbolCompany
13/05/202416:42GlobeNewswire Inc.Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance for 2024 TrinScreen HIV SalesNASDAQ:TRIBTrinity Biotech PLC
08/05/202415:36GlobeNewswire Inc.Trinity Biotech Welcomes Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and DevelopmentNASDAQ:TRIBTrinity Biotech PLC
08/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRIBTrinity Biotech PLC
07/05/202421:25Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
04/04/202412:30GlobeNewswire Inc.Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business UpdatesNASDAQ:TRIBTrinity Biotech PLC
28/03/202422:39GlobeNewswire Inc.Trinity Biotech plc to Announce Q4 and Fiscal Year 2023 Financial ResultsNASDAQ:TRIBTrinity Biotech PLC
08/03/202415:03GlobeNewswire Inc.Trinity Biotech Regains Compliance with Nasdaq Minimum Closing Bid Price RuleNASDAQ:TRIBTrinity Biotech PLC
15/02/202419:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRIBTrinity Biotech PLC
15/02/202417:34GlobeNewswire Inc.Trinity Biotech Plc Finalizes Effective Date of ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
13/02/202414:00GlobeNewswire Inc.Trinity Biotech Plc Announces Plan to Implement ADS Ratio ChangeNASDAQ:TRIBTrinity Biotech PLC
10/02/202400:51Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:TRIBTrinity Biotech PLC
08/02/202413:30GlobeNewswire Inc.Trinity Biotech to Present at Emerging Growth ConferenceNASDAQ:TRIBTrinity Biotech PLC
07/02/202413:30GlobeNewswire Inc.Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA CodeNASDAQ:TRIBTrinity Biotech PLC
01/02/202416:37Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
01/02/202416:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
31/01/202412:05GlobeNewswire Inc.Trinity Biotech Announces Q3 2023 Financial Results & Business UpdateNASDAQ:TRIBTrinity Biotech PLC
31/01/202412:02GlobeNewswire Inc.Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch a CGM Biosensor Device in China and IndiaNASDAQ:TRIBTrinity Biotech PLC
31/01/202412:00GlobeNewswire Inc.Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.NASDAQ:TRIBTrinity Biotech PLC
30/01/202422:23GlobeNewswire Inc.Trinity Biotech plc to Host Investor CallNASDAQ:TRIBTrinity Biotech PLC
02/01/202421:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
02/01/202421:13Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TRIBTrinity Biotech PLC
02/01/202419:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
27/12/202313:57GlobeNewswire Inc.Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to KenyaNASDAQ:TRIBTrinity Biotech PLC
19/12/202318:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
18/12/202321:30GlobeNewswire Inc.Trinity Biotech Announces Management ChangesNASDAQ:TRIBTrinity Biotech PLC
29/11/202314:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
28/11/202321:05GlobeNewswire Inc.Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held SharesNASDAQ:TRIBTrinity Biotech PLC
10/10/202321:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
10/10/202313:15GlobeNewswire Inc.Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of HealthNASDAQ:TRIBTrinity Biotech PLC
06/10/202321:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:TRIBTrinity Biotech PLC
 Showing the most relevant articles for your search:NASDAQ:TRIB

Your Recent History

LSE
EEE
Empire Metals
LSE
VOD
Vodafone
LSE
BIRD
Blackbird
LSE
TERN
Tern
LSE
SOLG
Solgold
LSE
PET
Petrel Resources
LSE
INSG
Insig Ai
LSE
ITV
Itv
LSE
PANR
Pantheon Resources
LSE
SCE
Surface Transforms
LSE
SAR
Sareum
LSE
VAST
Vast Resources
LSE
OTB
On The Beach
LSE
GDR
Genedrive
LSE
BOO
Boohoo
LSE
GOLD
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved